Intravenous busulfan before autologous stem cell transplantation in children with cancer

被引：0
作者：
Le Guyader, N. [1 ]
Landre, T. [1 ]
Haouy, S. [1 ]
Landman-Parker, J. [1 ]
Fasola, S. [1 ]
Auvrignon, A. [1 ]
Leverger, G. [1 ]
机构：
[1] Hop Armand Trousseau, Paris, France
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S302 / S302
页数：1
相关论文
共 50 条
  • [11] Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation
    Curtis, P. Huezo-Diaz
    Uppugunduri, C. R. S.
    Muthukumaran, J.
    Rezgui, M. A.
    Peters, C.
    Bader, P.
    Duval, M.
    Bittencourt, H.
    Krajinovic, Maja
    Ansari, Marc
    PHARMACOGENOMICS JOURNAL, 2018, 18 (01) : 64 - 69
  • [12] Association of CTH variant with sinusoidal obstruction syndrome in children receiving intravenous busulfan and cyclophosphamide before hematopoietic stem cell transplantation
    P Huezo-Diaz Curtis
    C R S Uppugunduri
    J Muthukumaran
    M A Rezgui
    C Peters
    P Bader
    M Duval
    H Bittencourt
    Maja Krajinovic
    Marc Ansari
    The Pharmacogenomics Journal, 2018, 18 : 64 - 69
  • [13] Toxicity and pharmacokinetics of i.v. busulfan in children before stem cell transplantation
    Oechtering, D
    Schiltmeyer, B
    Hempel, G
    Schwab, M
    Würthwein, G
    Mürdter, T
    Klingebiel, T
    Vormoor, J
    Gruhn, B
    Fleischack, G
    Boos, J
    ANTI-CANCER DRUGS, 2005, 16 (03) : 337 - 344
  • [14] Comparison of melphalan together with busulfan or treosulfan before autologous stem cell transplantation in AML in first remission
    Gurevich, E.
    Hayoz, M.
    Aebi, Y.
    Largiader, C.
    Kronig, M. -N.
    Bacher, U.
    Pabst, T.
    SWISS MEDICAL WEEKLY, 2020, : 16S - 16S
  • [15] Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation
    Schuler, US
    Renner, UD
    Kroschinsky, F
    Johne, C
    Jenke, A
    Naumann, R
    Bornhäuser, M
    Deeg, HJ
    Ehninger, G
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (04) : 944 - 950
  • [16] Pharmacokinetics and tolerability of intravenous busulfan in hematopoietic stem cell transplantation
    Cho, Yo-Han
    Lim, Hyun-Ae
    Lee, Mark Hong
    Kim, Inho
    Lee, Jong Seok
    Park, Seong yang
    Kim, Byoung Kook
    Yoon, Sung-Soo
    CLINICAL TRANSPLANTATION, 2007, 21 (03) : 417 - 422
  • [17] Unexpectedly high AUC levels in a child who received intravenous busulfan before stem cell transplantation
    T Nishikawa
    Y Okamoto
    T Tanabe
    Y Shinkoda
    Y Kodama
    M Higashi
    H Hirano
    K Arita
    Y Kawano
    Bone Marrow Transplantation, 2010, 45 : 602 - 604
  • [18] Unexpectedly high AUC levels in a child who received intravenous busulfan before stem cell transplantation
    Nishikawa, T.
    Okamoto, Y.
    Tanabe, T.
    Shinkoda, Y.
    Kodama, Y.
    Higashi, M.
    Hirano, H.
    Arita, K.
    Kawano, Y.
    BONE MARROW TRANSPLANTATION, 2010, 45 (03) : 602 - 604
  • [19] INTRAVENOUS BUSULFAN IN CHILDREN PRIOR TO HAEMATOLOGICAL STEM CELL TRANSPLANTATION, HOW NARROW IS THE THERAPEUTIC WINDOW?
    Bartelink, I. H.
    Bredius, R. G. M.
    Egberts, T. C. G.
    Suttorp, M. M.
    Bierings, M.
    Knibbe, C.
    Zwaveling, J.
    Boelens, J. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 71 - 72
  • [20] Safety, Efficacy, and Pharmacokinetics of Intravenous Busulfan in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
    Wall, Donna A.
    Chan, Ka Wah
    Nieder, Michael L.
    Hayashi, Robert J.
    Yeager, Andrew M.
    Kadota, Richard
    Przepiorka, Donna
    Mezzi, Khaled
    Kletzel, Morris
    PEDIATRIC BLOOD & CANCER, 2010, 54 (02) : 291 - 298
12345